 BOTHELL, Wash., Feb. 21, 2022 PRNewswire -- BioLife Solutions, Inc. NASDAQ: BLFS, a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies CGT and broader biopharma markets, today announced the Companys fourth quarter and full year 2021 financial results will be released after market close on Monday, February 28 th. 